$25M is a reasonable estimate of the end-user sales of ATryn in the first 12 months for the HD indication. These end-user sales will be booked by Leo, not by GTC. From these end-user sales by Leo, GTC will recognize about $6-7M in revenue and about $4M in profit, based on the company’s prior guidance on the economics of the collaboration (#msg-12430822).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”